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Abstract 
Three economically important swine diseases: Porcine Reproductive and Respiratory 
Syndrome (PRRS), Porcine Circovirus Associated Disease (PCVAD) and Swine influenza cost 
the US swine industry more than a billion dollars each year.  This study developed a fluorescent 
microsphere immunoassay (FMIA) to simultaneously detect antibodies to the causative 
pathogens: PRRSV, porcine circovirus (PCV2) and swine influenza virus (SIV).  The results 
showed that the multiplex assay possessed the predicted specificities. In the case of PRRSV NA, 
the assay displayed higher sensitivity when compared to a commercially available ELISA. The 
assay was employed to measure both IgG and IgM responses. The FMIA was found to possess 
several advantages over standard ELISA which include reduced sample volume, time and cost 
and provides a new tool for veterinary diagnostics.  
The FMIA was applied for swine disease surveillance in Hawaiian and Texan feral swine 
populations. The antibodies against PCV2 showed the highest prevalence among these three 
pathogens in both Hawaii and Texas. Hence we consider PCV2 as the most prevalent pathogen 
in Hawaiian and Texan feral pigs and this pathogen poses the greatest threat to commercial pigs. 
SIV seroprevelance increased from 2007 to 2010 in Hawaii State, suggesting an increasing risk 
for commercial pigs. Moreover, yearly surveillance in Texas State shows growth in seropositive 
response to all pathogens, particularly PCV2.  
The development of FMIA for detection of antibodies to multiple swine pathogens in 
serum samples offers an important alternative for swine disease surveillance in commercial and 
feral herds.   
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Chapter 1 - Introductions 
 Multiplex Fluorescent Microsphere-based immunoassay 
Fluorescent microsphere immunoassay (FMIA) is a protein detection assay in solution 
that incorporates the use of fluorescent microspheres as the binding surface for antigen-antibody 
complexes. Multiplex FMIA can detect more than one target proteins in a single sample.  In 
1997, Gorden and Mcdade from Luminex Corp. published their work regarding a novel assay for 
the simultaneous detection IgG, IgM and IgA of human serum samples in the same test tube 
(Gordon & McDade, 1997). At that time, the multiple fluorescent color sets of 
microspheres/beads carried 64 distinct colors (Kellar & Iannone, 2002). After 15 years of 
development, Luminex technology now offers up to 500 distinct color-coded beads to detect up 
to 500 target proteins. 
  
 Principle of FMIA xMAP Technology  
The FMIA xMAP Technology follows the principles of sandwich immunoassays. The 
polystyrene microspheres, called bead sets, are given up to 500 distinct color ‘addresses’ using 
internal dyes. The xMAP microsphere is a 5.6 micron-sized polystyrene sphere with a 
carboxylated surface (Figure 1.1A). Internal dyes with differing ratios of two spectrally distinct 
fluorophores create a family of 500 differentially spectrally addressed bead sets (Figure 1.1B). 
Different color ratios of red (emission at 658nm) and infrared dyes (emission at 712nm) 
distinguish one bead set from another (Wilson et al., 2006). The carboxylated surface of 
microspheres enables the coupling of a capture protein to the beads. The high surface-to-volume 
ratio of the microsphere provides more binding surface in the assay.  Each bead set is coated with 
a ‘capture’ protein (antigen) that reacts with the corresponding ‘target’ protein (antibody) in 
samples. In a multiplex assay, different bead sets are coated with different capture proteins to 
make the bead mixture. Subsequently, a secondary antibody labeled with biotin-phycoerythrin 
(PE) conjugate or directly with PE is reacted with the bead mixture to bind the target protein 
(antibody). Using an optical detection instrument, the fluorescence signals from internal dyes and 
PE are measured. The internal dyes identify each bead set. The PE dye acts as ‘reporter’ dye to 
measure the amount of target proteins (or antibodies) bound. The analysis software combines the 
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two signals to give a quantitative result of the different target proteins present in the sample. 
Using this process, xMAP Technology can perform up to 500 multi-assays within a single 
sample. 
The bead solution is analyzed by a fluorometric array reader: flow cytometric instrument 
(Luminex 200; Figure 1.2B) or imaging CCD instrument (Magpix; Figure 1.3B). The Luminex 
200 (Figure 1.2A) employs flow cytometric technology as the detection system (Sukhanova & 
Nabiev, 2008). A probe aspirates the bead solution from the assay plate and forces the beads 
through a 200 micron square flow channel one at a time. When beads pass through a specific 
position, the 532nm and 635nm wavelength lasers excite the reporter dyes and internal dyes, 
respectively. The reporter detector collects fluorescent signals between 565nm and 585nm.  The 
bead detector collects fluorescent signals at wavelengths 658nm and 712nm, and the ratio is used 
to classify each bead set (Sukhanova & Nabiev, 2008). 
The newly developed Magpix instrument (Figure 1.3A) employs imaging technology that 
differs from the flow cytometric technology of Luminex 200.  A probe aspirates the solution of 
magnetic beads and transfers the beads to a magnetic mat. The beads spread out as a monolayer 
on the magnetic mat. The 511nm and 621nm wavelength Light Emitting Diodes (LEDs) excite 
reporter dyes and internal dyes, respectively. A CCD imager acts as both reporter and bead 
detector (Sukhanova & Nabiev, 2008). 
               The xPONENT software is compatible with both Luminex 200 and Magpix instrument. 
The functions of this software include converting fluorescent signals to digital data, performing 
the analysis, and guiding system maintenance routines. The software calculates the mean 
fluorescence reporter intensity (MFI) for each bead set per sample. At least 100 beads from each 
set of microspheres are counted per sample.  Since the fluorescence from each bead is measured 
independently, sufficient replicates for statistical analysis are accumulated in every sample.  
 
 Comparison with ELISA 
The Enzyme-Linked Immunosorbent Assay (ELISA) (Malekzadeh et al., 2012), which is 
the traditional analysis method for detecting antibody, requires a separate assay for each target 
protein. In an indirect detection ELISA (sandwich immunoassay), an antigen is attached to the 
bottom of a well for capturing target primary antibody.  A secondary antibody linked to an 
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enzyme, often horseradish peroxidase (HRP), binds to a different region of the antigen.  When 
the substrate for the enzyme is added, the color signal generated is used for detection of the 
antibody of interest. The advantages of ELISA are ease-of-use, flexibility, and low cost.  The 
FMIA not only offers benefits of ELISA, but also has several advantages compared to the 
monoplex ELISA. First, FMIA shows greater specificity and sensitivity for two reasons: type of 
binding and method of detection. The capture proteins that are covalently bound to beads have 
higher avidity as opposed to the hydrophobic interaction in ELISA. The higher density of capture 
protein per surface area on beads and the reduced loss of protein in washing steps increase 
sensitivity.  The bead surface minimizes non-specific binding and, therefore, reduces 
background.  FMIA is based on direct fluorescence detection which improves sensitivity.   A 
second advantage is that multiple target antibodies can be detected at the same time. And third 
advantage of FMIA over ELISA is cost and time efficiency for detection of multiple target 
proteins.  
A comparison between ELISA and FMIA in terms of cost and time is presented in Table 
1-1 and Table 1-2.  
 
 Porcine Reproductive and Respiratory Syndrome virus (PRRSV) 
             Porcine Reproductive and Respiratory syndrome (PRRS), caused by Porcine 
Reproductive and Respiratory syndrome virus (PRRSV), is the most economically important 
infectious disease. The economic impact on the US swine industry was estimated at $560 million 
dollars per year (Neumann et al., 2005). PRRS symptoms in pigs include severe reproductive 
failure and respiratory distress. The reproductive failure occurs in sows and gilts including late-
term abortions, stillbirth, and premature farrowing.  In growing pigs, PRRS can cause increased 
mortality and decreased growth performance (Corzo et al., 2010). PRRSV is highly infections 
and can be transmitted by direct contact (oral fluids, nasal secretions, mammary gland secretions 
and semen) (Bierk et al., 2001) or by indirect routes. The indirect routes include contaminated 
boots, coveralls, aerosol, and so on (Otake et al., 2002) (Pitkin et al., 2009). PRRSV has been 
identified in air samples collected at 9.1 km from infected pig barn (Desrosiers, 2011). PRRSV is 
also an important component of various polymicrobial disease syndromes, such as porcine 
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respiratory disease complex (PRDC) and porcine circovirus associated disease (PCVAD) (Chand 
et al., 2012). 
PRRSV was first recognized clinically in pigs in the Netherlands and the United States 
in 1991 (Wensvoort et al., 1991) (Benfield et al., 1992). PRRSV is classified in the family 
Arteriviridae, along with equine arteritis virus (EAV), lactate dehydrogenase-elevating virus 
(LDV), and simian hemorrhagic fever virus (SHFV). The PRRS virus is a positive-sense; single-
stranded enveloped RNA virus. The genome is approximately 15kb and encodes ten open 
reading frames (ORFs) (Firth et al., 2011). The spherical virus particle, which has a diameter of 
about 50-65 nm, consists of a lipid envelope and a capsid core.  The capsid consists of the 
nucleocapsid (N) protein and the viral genome (Spilman et al., 2009). The envelope includes all 
structural proteins except the N protein. Multiple N proteins enclose the non-segmented viral 
RNA (Figure 1.4). PRRSV includes two genotypes: Type I (isolated from European Union) and 
Type II (isolated form North America). The two PRRSV genotypes show approximately 60% 
nucleotide identity according to sequence analysis (Hanada et al., 2005). 
 
PRRSV binds the heparin sulphate receptor (Delputte et al., 2002) and sialoadhesin 
(Delputte et al., 2007) receptor on surface of host cells (Kim et al., 2006). The virus enters cells 
by clathrin-mediated endocytosis. Host CD163 might be involved in viral uncoating (Van Gorp 
et al., 2008); however, the mechanisms of fusion and uncoating are not well understood. Virus 
replication, transcription and translation take place in the cytoplasm by the viral replication- 
transcription complex.  After assembly in the ER and Golgi complex, PRRSV virions are 
transported to the plasma membrane for release (Knipe & Howley, 2007). 
 
The N protein, encoded by ORF7, is the sole component of the PRRSV capsid, which is 
123 and 128 amino acids in length (Type I and Type II, respectively).  The NP gene is rarely 
mutated and is highly conserved (Chang et al., 2002) and immunogenic (Loemba et al., 1996). 
Antibodies against N protein can be detected as early as 5-7 days post-infection (DPI). The N 
protein is the earliest detected immunogenic protein compared with other immunogenic proteins, 
such as Nsp1, Nsp2, Nsp4, Nsp7, Nsp8, GP5, and M proteins. (Brown et al., 2009) (Mulupuri et 
al., 2008) (Jeong et al., 2010) .  
 
5 
 
 
 Porcine Circovirus Type 2 (PCV2) 
 
Porcine Circovirus Type 2 (PCV2) is associated with Porcine Circovirus Associated 
Disease (PCVAD) in pigs. PCVAD encompasses a group of diverse multi-factorial diseases 
including Post-weaning Multisystemic Wasting Syndrome (PMWS), Porcine Dermatitis and 
Nephropathy Syndrome (PDNS), porcine respiratory disease complex (PRDC), and reproductive 
disorders. It is recognized as a global, epizootic disease that causes significant economic losses 
to pig producers. PCV2 is considered necessary for disease, but the presence of PCV2 alone is 
not always considered sufficient for development of PCVAD.  PCV2 infection and replication in 
lymphoid tissues can lead to lymphoid depletion, which subsequently leads to 
immunosuppression. PCV2 is usually found with other swine pathogens, such as PRRSV, or SIV 
(Opriessnig & Halbur, 2012). 
 
PCV2 is a member of the Circoviridae family. Sequence analysis shows that PCV2 
isolates can be classified into two main genotypes; PCV2a and PCV2b (Segalés et al., 2008). 
Porcine circoviruses possess an ambisense single-stranded DNA genome in the form of a 
covalently closed circle. The genomes of PCV2a and PCV2b are 1,768, and 1,767 nucleotides 
(nt) in length, respectively. The genome sequences of PCV2a and PCV2b share an identity of 
approximately 95% (Fenaux et al., 2004). The PCV2 genome is composed of ORF1 (encodes 
two replicase proteins Rep and Rep’), ORF2 (encodes a capsid protein), and ORF3 (encodes an 
apoptosis protein). The 233-amino-acid capsid protein (CP), encoded by ORF2, is the only structural 
protein, which constitutes the outer protein of the PCV2 virus like particle (VLP). PCV2 VLP 
spans ~17nm and is composed of 60 capsid protein molecules arranged into 12 pentameric units 
(Figure 1.5).   
 
PCV2 can infect multiple cell types, including epithelial cells and monocyte/macrophage 
cells. The mechanisms of PCV2 entry are not well understood. It is believed that PCV2 uses a 
relatively common cell receptor to attach to and enter cells (Misinzo et al., 2006). After entry and 
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uncoating, the viral genome localizes to the nucleus, the site of virus replication.  CP contains an 
arginine rich basic N-terminus responsible for nuclear localization.   
 
Recently, an epitope in the C-terminal region of CP, CP(169-180), was identified as an 
immunodominant epitope.  Antibodies targeted to the CP(169-180) region were detected only in 
PCVAD affected pigs associated with relatively low neutralizing antibody (NA).  In the 
monomeric form, CP(169-180) is exposed on an outer loop, and acts as decoy epitope directing 
the main antibody response towards this region. However, the CP(169-180) is hidden within the 
VLP structure (Trible et al., 2011). Low levels of neutralizing activity associated with high levels 
of anti-PCV2 CP(169–180) antibody in PCVAD affected pigs explains the absence of protection 
following virus infection (Trible et al., 2012). However, vaccinated pigs almost exclusively 
recognize the polypeptide CP(43-233). Therefore, the measurement of antibodies against 
CP(169-180) provides the basis for diagnostic methods that can differentiate infected from 
protected animals .  
 
 Swine Influenza Virus (SIV) 
Swine influenza, caused by swine influenza A virus (SIV), is an acute respiratory disease 
affecting pigs of all ages. Clinical signs include the sudden onset of fever, sneezing and a barking 
cough. Infected pigs may exhibit breathing problems as well as loss of appetite. SIV is highly 
contagious among pigs and may cause considerable economic losses in an infected herd 
(Neumann & Kawaoka, 2011). Swine influenza (SI) was first recognized clinically in pigs in the 
Midwestern U.S., in 1918. With the increasing number of novel subtypes and the presence of 
multiple co-circulating strains, the prevention of SIV has become increasingly difficult. In 
commercial swine populations, influenza is an important component of the porcine respiratory 
disease complex (PRDC) (Wei et al., 2010). 
 
SIV type A is one of the five genera in the family Orthomyxoviridae. This virus is a 
negative-sense, single-stranded RNA virus with 8 segments. The spherical virus particle, which 
has a diameter of about 80-120 nm, consists of a lipid bilayer envelope, an inner shell of matrix 
proteins, and a nucleocapsid surrounding the viral genome (Figure 1.6). The envelope is 
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comprised of hemagglutinin (HA), neuraminidase (NA), and M2 proteins. A layer of M1 protein 
acts as the inner shell. The core of the virus particle, the ribonucleoprotein complex (RNP 
complex), includes the viral RNA segments, the nucleoprotein (NP), and the three subunits of 
viral polymerase (PB1, PB2, and PA). NP is the major viral protein in the RNP complex and 
multiple NPs coat individual segments of RNA. PB1, PB2, and PA are situated at the ends of the 
RNP complex. Subtypes are classified by antigenic and genetic properties of surface proteins 
haemagglutinin (HA) and neuraminidase (NA). Frequent mutations occur in the HA and NA 
regions of the virus resulting in "antigenic drift". So far there are 16 hemaglutinin (H 1-H16) 
subtypes and 9 neuraminidase (N1-N9) subtypes (Knipe & Howley, 2007).  Three virus subtypes 
(H1N1, H3N2 and H1N2) are most frequently identified in pigs and are spreading within swine 
populations worldwide (Vijaykrishna et al., 2011).  
 
SIV binds the sialic acid-containing receptor on surface of cells followed by clathrin-
mediated endocytosis for virus entry. At the low pH within the endosome, HA mediates fusion of 
the viral membrane with the endosomal membrane. M2 protein allows H+ ion influx into the 
virus particle, which disrupts protein-protein interaction between the core RNP complex and 
outer shell. This results in release of free RNP complex into the cytoplasm. NPs in RNP complex 
carry nuclear localization signals (NLSs) that bind with host importin α protein for transport 
across the nuclear membrane. Virus replication in the nucleus occurs via the viral polymerase 
complex.  After assembly, the export occurs via a host export receptor in a Crm1-dependent 
manner. 
 
The nucleoprotein (NP), which is 498 amino acids in length, coats and protects the virus 
RNA against degradation by various enzymes (Li et al., 2009).  The NP gene is rarely mutated 
and has more than 90% homology at nucleotide level among H1N1, H2N2, H3N2 and other 
subtypes of influenza type A virus (Ohba et al., 2007).  For example, the nucleoprotein (NP) of 
seasonal H1N1 virus contains 9 B-cell epitopes, four of which were conserved in 2009 pandemic 
H1N1 (Combadière et al., 2010). Serum antibody responses have been ascribed to the HA, NA, 
M2, NP, and M1 proteins (Couch, 2003) . The antigenic drift and shift of the surface antigens 
make antibody responses against HA and NA frequently variable. The high conservation of NP 
antigen and the known longevity of antibody responses (Amanna et al., 2007) suggest it as a 
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suitable antigen for detection of virus-specific antibodies of all subtypes of SIV (LaMere et al., 
2011).   
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 Figures and Tables 
 Figure 1.1 The xMAP microsphere  
(A) Carboxylated surface of microsphere; (B) Luminex internally color-codes microspheres with 
precise concentrations of various fluorescent dyes yielding up to 500 distinctly colored bead sets. 
(www.luminexcorp.com) 
 
 
 
 
 
 
 
(A) The red laser excites the internal dyes to distinguish the microsphere set and the green laser 
excites the fluorescent dye on the reporter molecules for the assay output. (B)Picture of luminex 
200 machine from www.luminexcorp.com 
 
 
 
 
 
 
 
 
 
Figure 1.2 Schematic of Luminex 200  
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 Figure 1.3 Schematic of Magpix  
(A) Magpix holds beads in a monolayer with a magnetic mat. The 511 nm (green) and 621 nm 
(red) LEDs excited reporter dyes and internal dyes respectively.  CCD camera takes an image of 
the beads in the magnetic mat. (B) Picture of Magpix machine form www.luminexcorp.com 
 
 
  
 
 
Figure 1.4 Schematic representation of PRRSV particle  
(Provided by Benjamin Trible) 
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Figure 1.5 PCV2 CP subunit model structure and assembly into a viral capsid.  
(A) The ribbon model of the CP subunit with helices, loops and sheets shown in green, blue and 
red, respectively.  (B) A CP subunit placed in the context of viral capsid.  The remaining CP 
subunits are depicted in gray.  Both models are based on the data of Khayat et al. (Khayat et al., 
2011) and reproduced using the UCSF Chimera computer program (Pettersen et al., 2004). 
(Figure provided by Benjamin Trible).  
 
 
 
Figure 1.6 Schematic representation of SIV  
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Table 1-1 Cost comparison of FMIA vs. ELISA.  
Example is for the detection of swine antibody 
  Cost per 96 Well Plate 
Item  Cost ELISA Magpix Bioplex 
96-well plate  $1.73 $3.66 $3.66 
Magplex beads $630/ml NA* $12.60 $25.20 
Antigen for detection $20/100ug $8.00 $0.4 $0.8 
Anti-swine IgG conjugate-biotin $96/2ml NA $0.45 $0.45 
Goat serum for blocking $204/500ml $1.63 $3.76 $3.76 
Streptavidin-PE $270/ml NA $5.40 $5.40 
Anti-swine IgG conjugate-
peroxidase 
$96/2ml $0.30 NA NA 
TMB-Substrate $153/250ml $6.12 NA NA 
Plate sealing film  $0.82 $0.88 $0.88 
Stop solution  $27.10/1L $0.38 NA NA 
Buffers, tips. etc  $2.00 $2.00 $2.00 
 TOTAL $20.98 $29.15 $41.75 
 Two tests $41.96 $41.79  
 Three tests $62.94 $54.43  
*NA, not applicable     
 
 
Table 1-2 Time comparison of FMIA vs. ELISA 
FMIA (Magpix) ELISA 
Step Time 
(Min) 
Step Time 
(Min) 
  Block plate 65 
Prepare standards and samples  40 Prepare standards and samples  40 
Prepare beads, Pipette 50 uL to each 
well 
10 Pipette200 μL sample or standard to 
each well 
10 
Pipette 50 μL of sample or standard to 
each well 
10 Mixing 2 
Incubation 40 Incubation 60 
Wash step (3x) using magnetic plate 10 Wash step (3x) 5 
Prepare detection antibody solution 2 Prepare detection antibody 2 
Pipette 50 μL per well of antibody 3 Pipette 100 μL per well of antibody  3 
Incubation 30 Incubation 60 
Wash step  10 Wash step 5 
Prepare streptavidin-PE 2 Prepare substrate solution 2 
Pipette 50 μL Strep-PE per well 3 Pipette 100 μL substrate per well 3 
Incubation 30 Incubation 20 
Washing step  10 Pipette 100 μL stop per well 3 
Assay read-out 70 Assay read-out 10 
Total  270min Total  290min 
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Chapter 2 - Development of multiplex fluorescent immunoassay to 
multiple swine pathogens 
 
 Introduction  
 
PRRSV, SIV and PCV2 are economically important and are widely distributed in both 
domestic and feral pigs. To date, few multiplex tests are available for antibody detection, 
especially for veterinary use. The FMIA has been developed for simultaneous detection of 
antibodies to PCV2 and PRRSV (Lin et al., 2011). In this study, we have applied the FMIA to 
develop a multiple serological detection test for PCV2, SIV and PRRSV as an efficient tool for 
diagnosis and surveillance of swine diseases. To develop the assay, we chose suitable antigens 
for each pathogen. The ORF7 gene, which encodes the N protein, of PRRSV, is highly 
conserved and immunogenic. The N protein is the earliest detected immunogenic protein, which 
was observed in diagnostic tests as early as 5-7 DPI. Hence, the N protein is the most suitable 
antigen to use for the surveillance of PRRS disease. The capsid protein (CP) of PCV2 is the only 
structural protein, which constitutes the outer protein of virion. For surveillance of PCV2-
associated disease, two different antigens were used: CP (43-233) and CP (160-233). We chose 
CP (43-233), which includes all the known immunogenic epitopes, as antigen to monitor PCV2-
associate disease.  Antibodies targeted to the CP (160-233) region were detected only in PCVAD 
affected pigs associated with relatively low neutralizing antibody (NA) response.  Therefore, we 
chose CP (160-233) as antigen to distinguish unprotected animals after PCV2 infection. The 
nucleoprotein (NP) of SIV is a group specific structural protein and is the major internal 
component of the virion. The highly conserved NP elicits immunity against all subtypes of SIV.  
Therefore, NP was selected as target antigen for surveillance of swine influenza disease.  
 
The approach used for this study was as follows. Specific antigens of each pathogen were 
coupled to different color bead sets which were used to develop a multiplex assay. The assay was 
optimized by testing various parameters of positive and negative samples, such as sensitivity, 
specificity, reproducibility between different coupling batches and cross reactivity among 
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different bead sets. The results of the multiplex assay were compared with commercial ELISA. 
We applied this multiplex assay to identify early stage infection by detection of IgM antibody. 
 
 
 Methods 
 
 Expression and purification of recombinant antigen proteins 
SIV NP, PRRSV NA N, PRRSV EU N, PCV2 CP (43-233), and PCV2 CP (160-233) 
antigens proteins were expressed as fusion proteins (His-tag and ubiquitin) in the pHUE vector 
using an E. coli expression system. The pHUE vectors containing the target protein cDNA were 
transformed into the BL-21(DE:3) E. coli cell line. E. coli were cultured in LB with ampicillin at 
37
o
C until they reached an OD600 of 0.4-0.6. For the purpose of induction of protein expression, 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to E. coli cultures to a final 
concentration of 1.0ug/ml. After addition of IPTG, bacteria were grown for an additional 4 hours 
and then harvested by centrifugation at 4,000g for 10 minutes. 
 
Proteins were purified using a PrepEase His-Tagged Protein Purification High yield Kit 
(USB). The bacterial pellet was subjected to three freeze thaw cycles at -80
o
C and RT 
respectively. Then the pellet was suspended in 5mL of 1X lysis, equilibration, and wash (LEW) 
buffer (USB) and 50uL of EDTA free protease inhibitor cocktail (THERMO scientific). After 
adding lysozyme to a final concentration of 1mg/mL, the mixture was incubated on ice for 30 
minutes. Sonication was then performed six times for 10 seconds each time, with 30 seconds 
incubations on ice between bursts. The bacterial lysate was then ultra-centrifuged at 20,000g for 
30 minutes. The supernatant was then filtered through a 0.45um PVDF filter (Fisher) to get 
soluble proteins. In order to capture the 6X-His tagged target proteins, the filtered lysate was 
added to a Ni-TED mini column (USB). After washing with 3 column volumes of 1X LEW, the 
target proteins were eluted in four 1mL aliquots using 1X elution buffer (USB). 
 
Purified protein concentrations were measured using Protein Assay (Bio-Rad). Briefly, 
purified polypeptides were mixed with 200uL of 1X dye reagent in a 96 well plate (flat bottom 
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Fisher). Absorbance values of each well were determined by reading at 595nm on a precision 
microplate reader (Molecular Devices). Protein concentrations were then determined by 
comparison to BSA standard protein concentrations. 
 Bead coupling protocol 
The purified antigen proteins were covalently coupled to Luminex MagPlex® 
polystyrene, carboxylated beads with appropriate beads address. Briefly, 0.5mL of commercial 
beads (1.25 x 10
7 
beads/mL) were taken from 4 °C and warmed to room temperature in a USA 
Scientific microcentrifuge tube.  Beads should be protected from prolonged exposure to light 
throughout this procedure. The tube was placed into a magnetic separator for 1 minute to remove 
the supernatant. Beads were washed once with 100 µL of dd-H2O and tube was sonicated for 
approximately 20 seconds. Beads were resuspended in 80 µL of sodium dihydrogenphosphate 
(NaH2PO4, 0.1M, pH 6.2) after removing supernatant, vortexed gently, and sonicated for 20 
seconds. Ten micoliters of 50 mg/mL Sulfo-NHS (N-hydroxysulfocuccinimide, Thermo 
Scientific, Rockford, USA) and 10 μL of 50 mg/mL EDC (N-(3-dimethylaminopropyl)-N-
ethylcarbodiimide Thermo Scientific, Rockford, USA) were added successively to the beads and 
vortexed gently. For the purpose of activation, beads were incubated for 20 minutes at room 
temperature with gentle mixing. The beads were washed twice with 250 μL phosphate buffered 
saline (PBS), pH 7.4 by vortexing and sonication for approximately 20 seconds. The activated 
and washed beads were resuspended in 100 μL PBS.  Recombinant protein (25 uL) was added 
and total volume was brought to 500 μL in PBS. The tube was gently rotated on a shaker 
Rotisserie (Thermo Scientific) for two hours at RT in the dark for the coupling reaction to occur. 
Coupled beads were washed three times with 500 µL of PBS plus 4% goat serum (PBS-GS). 
Lastly, 1000uL PBS-GS was added to the washed beads to prepare bead stocks, which were 
stored at 2-8°C in the dark until use. Antibody detection protocol 
For reaction with samples, bead stocks were diluted in PBS-GS to a working 
concentration of 2500 coupled beads per 50 µL working solution. Due to the light sensitive 
nature of the fluorescent assay, all procedures were performed in the dark by sealing the plate 
with foil, except while adding and removing of components. Fifty microliters of a 1:400 diluted 
serum sample was added to each test well of a 96-well plate (Costar polystyrene white, round 
bottom 96-well plate, Corning, NY) along with 50 µL of the bead working solution. The plate 
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was incubated at room temperature for 40 minutes on a plate shaker (Thermo Scientific),  the 
supernatant was dumped with firm shakes by holding the assay plate onto a magnetic plate, and 
the assay plate was washed three times with 190 µL of PBS-GS. The bead-antibody complex 
was incubated with 50 µL of biotin-SP-conjugated affinity purified goat anti-swine secondary 
antibody (IgG, 2ug/mL,Jackson ImmunoResearch) or biotin-labeled affinity purified goat anti-
swine IgM (KPL, 2ug/mL,Gaithersburg, MD) in the dark at RT on a plate shaker for 30 minutes. 
After incubation, the plate was washed three times with PBS-GS, and 50 µL of PBS-GS 
containing 2 µg/mL streptavidin-conjugated phycoerythrin (SAPE, Moss, Inc., Pasadena, 
Maryland) were added to each test well and incubated for 30 minutes at room temperature with 
shaking. The supernatant was dumped and the plate was washed three times with PBS-GS. The 
beads were resuspended in 100 µL of PBS-GS per well, and the assay plate was read on the 
MAGPIX instrument.  
 
 Software and statistical analysis 
 
              Data were analyzed with the software Luminex
®
 xPONENT 4.2, and the mean 
fluorescence intensity (MFI) for each sample was determined. The MFI is directly proportional 
to the amount of antibody bound to the microspheres. The MFI for at least 100 microspheres 
corresponding to each individual antigen was recorded for each well. All reported MFI 
measurements were background corrected. 
The presence or absence of antibodies to each swine pathogen was evaluated by 
calculating the sample to positive ratio (S/P ratio). Positive and negative controls were performed 
for each plate. 
 
S/P ratio = (Sample mean – negative control mean)/(positive control mean – negative control mean) 
 
IDEXX ELISA also employs S/P ratio to analyze data. S/P ratio threshold was fixed at 0.4, for 
positive and negative controls which were provided by this commercial ELISA kit.   
The determination of P values, t-test, or F-test between groups were performed by Excel 
data analysis function.  
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 Establishment of control standards 
For the positive and negative controls, serum samples were collected from infected 
experimental animals and uninfected animals. The sera corresponding to the five bead sets were 
serially titrated with 2-fold dilutions from 1:100 to 1:6400. Fifty microliters of serially diluted 
serum samples were added to corresponding wells containing multiple coupled bead sets. 
Standard protocol for detection was performed. The results were visualized as regression curves 
(Figure 2.1). For optimum discrimination between positive and negative samples the baseline 
negative sample should be at least 10 times lower than a positive sample. Based on this criterion, 
1:400 was chosen as sample dilution for reaction. Samples that had large quantities were selected 
as controls for long-term usage. The mean fluorescence intensity (MFI) of positive controls were 
in the range of 15,000 to 30,000 and that of negative controls were from 300 to 1,000. Five 
positive controls for each antigen were chosen. Three negative controls were follows: SIV and 
PRRSV NA shared one negative control, PCV2(43-233) used the negative control which also 
used as SIV positive control, and PRRSV EU and PCV2 (160-233) had separate negative 
controls.  
 
 Results 
 Diagnostic sensitivity and specificity for detection of antibodies against PRRS NP 
Sensitivity is defined as a test's ability to identify positive results, and a measure of the 
proportion of actual positives which are correctly identified. Specificity measures the proportion 
of negatives which are correctly identified, and relates to the test's ability to identify negative 
results. To measure the diagnostic sensitivity and specificity, two experimental groups of pigs 
were tested. The first group included 198 three weeks old healthy PRRSV antibody-negative 
uninfected pigs. The second group included 491 experimentally PRRSV infected pigs for which 
samples were collected 42 days post infection. The pigs were euthanized on day 42. The cutoff 
value was determined by optimal balance of diagnostic sensitivity and specificity as 0.2 (Figure 
2.2).  Greater than 99% diagnostic sensitivity and specificity were achieved in PRRSV NA N 
antigen protein-based FMIA. Validate this cutoff S/P ratio (0.2) in 711 PRRSV negative field 
pigs, indicates good specificity (Figure 2.3) 
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 Coupling reproducibility 
 To assess reproducibility of different coupling batches of each bead set, samples of each 
pathogen and controls were tested by FMIA.  Each sample was run 18 times with coupling 
batch1 and 21 times with coupling batch2. Comparisons were performed between the two 
coupling batches by t-test (Table 2-2).  The results show that 57.5% samples have statistical 
differences between two coupling batches according to MFI values. However, only 25% samples 
show statistical differences after S/P calculation.  
 
 Comparison of PRRSV FMIA with ELISA 
In order to compare the PRRSV FMIA with the standard IDEXX ELISA test, 183 three 
week-old pigs were infected with PRRSV and bled at 4, 7, and 11 DPI. Serum samples were 
used to perform ELISA and FMIA. Serum samples were diluted to 1:400 in FMIA followed by 
standard protocol and data analysis to obtain results. The ELISA was performed by the KSVDL.  
Samples were diluted to 1:40 and 100ul of diluted samples was dispended into a 96-well antigen-
coated plate (provided in IDEXX PRRSV Antibody Test Kit). The plate was incubated at room 
temperature for 30 minutes, the supernatant was dumped into a waste reservoir, and the assay 
plate was washed three times with 300 µL of wash solution. Anti-swine secondary antibody 
labeled with HRP (100ul) was dispensed into each well followed by incubation for 30 min, then 
the supernatant was dumped and the plate was washed three times with 300ul wash solution. 
TMB substrate at 100 µL was added to each test well and incubated for 15 min at room 
temperature, followed by100ul Stop solution to stop the reaction. The absorption values of 
samples and controls were measured at A650. The presence or absence of antibody to PRRSV is 
determined by calculating the S/P ratio. If the S/P ratio is greater than or equal to 0.40, then the 
sample is classified as positive for PRRS antibodies, otherwise, this sample is classified as 
negative.  
 
The results of FMIA were compared to the commercially available ELISA (IDEXX 
Laboratories, Inc.) (Figure2.4). At 4 days post infection (PI), FMIA indicated that 4% of samples 
were positive compared to 0% in ELISA.  At 7 days PI, the percentage of positive samples was 
93% in FMIA compared to 41% in ELISA. The two assays showed the same 100% positive 
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results in samples 11 days PI. FMIA showed higher sensitivity in day 4 and day 7 PI in 
comparison with ELISA (Table 2-1). 
 
Detection of PRRSV pan-Ig and IgM antibodies 
Seven 3 week old pigs were infected with PRRSV. Serum samples were collected at 4, 7, 
11, 14, 21, and 28 days post infection (DPI).  Two FMIA assay were run using different 
secondary antibodies to detect swine pan-Ig (IgG and IgM) and IgM antibodies against PRRSV 
NA N protein. Goat anti-swine IgG (H+L) which can react with whole molecule swine IgG and 
the light chains of other swine immunoglobulins was used to detect pan-Ig. Goat anti-swine IgM 
which reacts specifically with swine IgM was used to detect IgM.   The results are presented in 
Figure 2.5. Anti-PRRSV IgM antibodies appeared in serum by 7 DPI and reached a peak by 11 
DPI, and then declined rapidly to low levels after 2-3 weeks post infection. Anti-PRRSV pan-Ig 
antibodies were first detected 7 DPI, peak at 14 DPI, and remained constant until 28 DPI. The 
trend of antibodies confirmed FMIA can be used to detect Pan-Ig and IgM antibodies in serum 
samples.  
 
 Comparison of single assays with the multiplex format 
In developing the FMIA, assays are developed as single assays and combined into a 
multiplex format.  After validating each individual FMIA in singleplex format, a multiplex (5-
plex) assay was developed by combining the singleplex assays together. The multiplex assay was 
compared with the singleplex assays to check whether there was any cross-reactivity among bead 
sets. Each serum sample was first tested in a singleplex format and then testing in a multiplex 
format with all five bead sets. As show in Figure 2.6, Comparisons were performed between 
singleplex and multiplex assay of each bead set by Anova F -test.  All the P-values of F-test 
were greater than 0.05, which suggested there was no statistically significant difference between 
multiplex and singleplex assay for each bead set. Thus, there is no cross-reactivity in the 
presence of multiple protein-coupled microspheres.  
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 Figures and Tables  
Figure 2.1 Two-fold dilution of positive controls (A) and negative controls (B) 
The different color lines stand for different bead sets. The horizontal axis stands for dilutions of 
internal standard samples. MFI, mean fluorescence intensity 
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The black x’s are from pigs experimentally infected with PRRSV. The red x’s were samples 
from a PRRSV negative herd. The horizontal dotted cutoff line between the positive and 
negative populations represents the cutoff value (99.6% diagnostic sensitivity and 100% 
specificity).The vertical axis is the S/P ratio 
 
 
 
Figure 2.3 Validate cutoff value of S/P ration in PRRSV negative field pigs 
The black x’s are from field pigs without PRRSV infection.   
 
 
Figure 2.2 Diagnostic sensitivity and specificity of PRRSV FMIA.   
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Figure 2.4 Comparison of PRRSV FMIA and ELISA 
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Figure 2.5 IgM and pan-Ig responses following PRRSV infection 
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Figure 2.6 Comparison of assay run as a "singleplex" (blue) versus multiplex format (red) 
 
 
Table 2-1 Sensitivity comparison of PRRSV FMIA of ELISA  
Test Percent of samples showing a positive result 
DAY 4 DAY 7 DAY 11 
FMIA 4% 93% 100% 
ELISA 0% 41% 100% 
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Table 2-2 Comparing between different coupling batches to estimate reproducibility 
 
P value P value
samples mean SD mean SD mean SD mean SD NA
1 2282.2 373.8 3228.5 869.4 0.0001 0.071 0.013 0.094 0.022 0.0002
2 1814.5 311.3 2133.9 572.2 0.034 0.052 0.008 0.054 0.014 0.49
3 5150.8 1517.9 6401.9 1395.4 0.011 0.189 0.058 0.212 0.036 0.16
4(positive) 24792.5 2516.2 27645.2 3120.9 0.003 1.000 0.000 1.000 0.000 NA
5 12030.9 1589.3 14679.7 2200.1 0.0001 0.471 0.047 0.520 0.057 0.03
6 467.3 131.9 479.7 123.6 0.76 -0.004 0.005 -0.006 0.004 0.08
7 760.4 165.1 902.7 199.1 0.019 0.008 0.005 0.009 0.004 0.5
8(negative) 554.8 109.7 648.2 131.6 0.02 0.000 0.000 0.000 0.000 NA
1 23867.5 3039.5 24467.3 2169.8 0.49 1.243 0.202 1.283 0.172 0.51
2(positive) 19620.2 3319.6 19531.3 3468.4 0.93 1.000 0.000 1.000 0.000 NA
3 986.2 365.8 847.7 282.8 0.2 0.033 0.010 0.026 0.007 0.01
4(negative) 330.7 123.0 328.5 95.4 0.95 0.000 0.000 0.000 0.000 NA
5 31774.0 7200.9 30821.4 4399.3 0.65 1.656 0.122 1.604 0.141 0.24
6 7948.4 2354.3 7010.1 1728.4 0.17 0.391 0.073 0.346 0.046 0.03
7 30379.1 3375.3 29758.7 3077.9 0.55 1.575 0.131 1.560 0.189 0.76
8 36200.7 10539.4 32653.4 4706.3 0.19 1.835 0.232 1.706 0.219 0.08
1 24496.2 3860.9 29255.7 3266.3 0.0002 0.801 0.101 0.914 0.105 0.001
2 211.3 140.0 143.6 35.9 0.06 -0.013 0.007 -0.014 0.007 0.58
3 13407.2 2396.9 19812.1 3874.9 4E-07 0.428 0.052 0.610 0.107 1E-07
4 14510.4 2893.8 22824.4 4136.9 1E-08 0.463 0.056 0.706 0.109 5E-10
5 7364.3 1243.5 13039.1 3257.5 8E-08 0.216 0.043 0.395 0.090 7E-09
6(positive) 30697.2 5411.4 32018.7 2210.8 0.34 1.000 0.000 1.000 0.000 NA
7 5803.2 1516.6 13200.1 4643.2 3E-07 0.173 0.034 0.399 0.136 2E-07
8(negative) 602.0 335.5 596.8 238.0 0.95 0.000 0.000 0.000 0.000 NA
1(positive) 20534.5 2906.5 24662.4 2676.4 6E-05 1.000 0.000 1.000 0.000 NA
2 8244.3 2519.1 10418.5 2372.5 0.009 0.389 0.127 0.409 0.071 0.56
3(negative) 584.8 214.2 470.4 139.4 0.06 0.000 0.000 0.000 0.000 NA
4 17487.3 3592.0 21481.1 3293.3 0.001 0.863 0.212 0.866 0.070 0.94
5 6434.8 1419.0 8660.2 1911.3 0.0003 0.282 0.120 0.337 0.057 0.1
6 12687.4 2829.5 14895.4 3170.6 0.02 0.625 0.192 0.594 0.102 0.54
7 14832.2 1531.7 17624.9 2523.0 0.0002 0.732 0.153 0.708 0.053 0.54
8 1334.4 570.2 1105.0 280.3 0.13 0.040 0.025 0.027 0.012 0.053
1 1038.2 250.6 1576.9 546.1 0.0003 0.015 0.014 0.034 0.022 0.003
2 2738.4 858.9 2700.9 868.8 0.89 0.098 0.034 0.088 0.025 0.3
3 259.3 81.3 348.9 126.8 0.01 -0.024 0.012 -0.026 0.007 0.61
4 284.8 110.5 412.1 127.2 0.001 -0.022 0.013 -0.023 0.009 0.87
5(negative) 727.3 237.4 876.4 273.0 0.08 0.000 0.000 0.000 0.000 NA
6 8389.7 2716.2 8556.8 1857.1 0.84 0.309 0.183 0.376 0.063 0.15
7(positive) 21004.8 2517.6 21291.2 2793.0 0.74 1.000 0.000 1.000 0.000 NA
8 36394.2 11562.7 32596.9 4713.6 0.2 1.756 0.549 1.559 0.181 0.16
*NA, not applicable   SD, standard deviation
S/P
PCV2 (43-
233)
PRRSV NA
PRRSV EU
   
PCV2(160-
233)
coupling1 coupling 2coupling 2coupling1
SIV
MFI
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Chapter 3 - Application of multiple FMIA--Simultaneous detection 
of antibodies against swine pathogens in feral swine 
 Introduction 
Feral swine are free ranging swine which were introduced into the USA by early 
European settlers over 300 years ago. USDA Wildlife Services recently estimated that there are 
3-6 million feral swine in the United States compared with 1-2 million in 2004. Their 
distributions appear to be expanding from 39 states (2004) to 45 states (SCWDS, 2012).   Recent 
studies have indicated that feral swine act as reservoirs of important viral and bacterial pathogens 
that affect commercial swine (Wyckoff et al., 2009) (Corn et al., 2009) (Corner, 2006). Disease 
agents may be transmitted by various routes, including direct contact (Hahn et al., 1997) or 
indirect contact via contamination of food, water, or fomites (Pritchard et al., 2005). 
Feral swine might play an important role in the epidemiology of swine pathogens, such as 
swine influenza (SIV), porcine circovirus 2 (PCV-2), and porcine respiratory and reproductive 
syndrome (PRRSV), which affect commercial swine in the United States. The objectives of this 
study were to determine the prevalence of antibodies against SIV, PRRSV, and PCV2 in selected 
regions of Hawaii State and Texas State. 
 
 Materials and methods 
 Hawaii sample collection  
Serum samples from 345 feral swine were collected from Oahu and Hawai’i islands in 
the state of Hawaii (Figure 3.1). Serum sample were collected by field biologists of wildlife 
service during 2007-2010 as part of the USDA disease surveillance program.  
 
 Texas sample collection  
Serum samples of 230 feral swine were collected from Aransas, Calhoun, Coke, Leon, 
Webb and Zapata counties in the state of Texas (Figure 3.2). Serum sample collections were 
done by wildlife service’s field biologists during 2007-2010 as part of the USDA disease 
surveillance program.  
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 Luminex assay 
Feral serum samples were diluted 1:400 in PBS-GS buffer and tested following the 
antibodies detection protocol as described previously. A panel of five selected positive serum 
samples and three negative serum samples were used as controls in all assays (Table 3.1). 
 
 Results 
 Seroprevalence for Hawaii 
Seroreactivity was determined for pan-Ig and IgM antibodies against SIV NP, PCV2 CP 
(43-233), PCV2 CP (160-233), PRRSV NA N, and PRRSV EU N proteins (Figure 3.3). PCV2 
pan-Ig antibody was the highest among these four pathogens at 61% followed by SIV at 7% and 
PRRSV EU at 5%. Prevalence of the PRRSV NA pan-Ig antibody showed the lowest positive 
percentage at 3.5%. The percentage of multiple infections in Hawaiian feral pig population is 
7.8% (Figure 3.6). The 10% pan-Ig against PCV2 CP (160-233), which also show pan-Ig against 
PCV2 CP (43-233), indicate this 10% feral pigs have a low protective response. Co-infections of 
PRRSV and SIV with PCV2 were more frequent than co-infection of SIV with PRRSV (Figure 
3.6). Two feral pigs were detected by pan-Ig as having antibodies against all 3 pathogens. IgM 
antibodies were detected against the 5 tested antigens which indicated the presence of an early 
stage of infection for all 4 pathogens. Seroprevalence of IgM was less than or equal to 3% 
(Figure 3.3). 
 
The seroprevalence of the antigens was also analyzed for the sample collection year 
(Figure 3.4). The percentage of seropositive responses to PCV2 was relatively stable and PRRSV 
seroprevalence over time remained low. However, the percentage of seropositive responses to 
SIV increased from 0% of 2007 to 19% of 2010. 
 
To investigate geography-specific pan-Ig and IgM antibody seroreactivity, the serum 
samples from each of the two islands were compared.  The overall animal level seroprevalence 
indicates that Oahu Island has a higher rate of disease than Hawai’i Island for both pan-Ig and 
IgM (Figure 3.5). 
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 Seroprevalence for Texas 
 
Texas swine pathogens seroreactivity was determined for the pan-Ig and IgM antibodies 
against SIV NP, PCV2 CP (43-233), PCV2 CP (160-233), PRRSV NA N, and PRRSV EU N 
antigen proteins (Figure 3.7). The positive percentage for each antigen was determined by using 
the calculated cutoff values. Seroprevalence of the PCV2 pan-Ig antibody was the highest among 
the pathogens at 54% followed by SIV at 3% and PRRSV EU at 1%. Antibodies to PRRSV EU 
were not detected in sera from any of the 230 samples collected in Texas.  IgM antibodies were 
detected against all 5 antigens which indicate the presence of an early stage of infection for all 4 
pathogens. Seroprevalence of IgM was less than or equal to 4% (Figure 3.7). 
 
To investigate geography-specific antibody seroreactivity, the samples from each of  the 
6 counties were compared (Figure 3.7).  Webb County possessed the highest prevalence of PCV2 
antibodies (89.7%) followed by Aransas County(82.3%) and Zapata County(56.9%). The other 
three counties were less than 41%. Coke County possessed the highest prevalence of SIV 
antibodies (13.6%) followed by Aransas County (8.6%).  Antibodies to SIV were not detected in 
Calhoun, Leon and Webb Counties. Three serum samples were antibody positive for PRRSV 
NA, one in Zapata County, two in Webb County. 
 
The seroprevalence of the antigens was also analyzed for the sample collection year 
(Figure 3.8). It can be seen that 2010 had the highest percentage of seropositive responses to all 
antigens, in particular the PCV2 antigen. Antibodies to SIV first appeared in 2010. Three serum 
samples were antibody positive for PRRSV NA, one was detected in 2008, while two were 
detected in 2010.  
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 Figures and Tables  
Figure 3.1 Map of Hawaii showing sample collection sites. 
Red dots represent the general locations of feral swine sample collection. 
 
 
 
Figure 3.2 Map of Texas showing sites of sample collection.   
Red colors show the location of the 6 counties where samples were collected. 
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Figure 3.3 Seroresponses to PCV2 CP (43-233), PCV2 CP(160-233), PRRSV NA N, PRRSV 
EU N, and SIV NP antigen in feral swine populations in Hawaii.  
Each circle represents one sample; horizontal lines represent cutoff values. Percentage values 
indicate seropositivity. MFI, median fluorescent intensity. S/P, sample over positive. 
 
 
Figure 3.4 Sample collection year related seroprevalence of PCV2, PRRSV NA and SIV in 
Hawaiian feral swine populations. 
 
 
 
 
 
32 
 
Figure 3.5 Geographic-related seroprevalence of PCV2, PRRSV NA and SIV NP pan-Ig 
(left) and IgM (right) antibodies in feral swine populations, state of Hawaii.  
The population was divided into 2 islands: Hawai’i (n = 52) and Oahu (n = 293). Each circle 
represents one serum sample, and the horizontal lines represent cutoff values. MFI, median 
fluorescent intensity. S/P, sample over positive.  
 
 
Figure 3.6 Pattern of pan-Ig antibody distribution in the Hawaiian feral pig population.   
The numbers in the brackets indicate the total positive samples for the corresponding virus. The 
20 PRRSV positive samples include PRRSV NA and EU. 
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Figure 3.7 Seroresponses to PCV2 CP (43-233), PCV2 CP(160-233), PRRSV NA N, PRRSV 
EU N, and SIV NP in feral swine populations in Texas. 
 
 
Figure 3.8 Seroprevalence in different Texan counties. 
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Figure 3.9 Sample collection year related seroprevalence of PCV2, PRRSV NA and SIV 
pan-Ig antibodies in Texan feral swine populations 
 
 
 
Table 3-1 Map of 96-well plate of FMIA.  
Blank stands for blank control(PBS-GS buffer); P1 stands for PRRSV NA positive control; P2 
stands for PRRSV EU positive control; P3 stands for PCV2 CP(43-233) and PCV2 CP(160-233) 
positive control; P4 stands for SIV positive control; P5 stands for PRRSV NA IgM positive 
control; N1 stands for PRRSV NA and SIV negative control; N2 stands for PCV2 negative 
control; N3 stands for PRRSV EU negative control; S1-S78 stand for feral serum samples 1-78. 
Blank  
P 4 N 3 S 7 S 15 S 23 S 31 S 39 S 47 S 55 S 63 S 71 
Blank  P 4 N 3 S 8 S 16 S 24 S 32 S 40 S 48 S 56 S 64 S 72 
P 1 P 5 S 1 S 9 S 17 S 25 S 33 S 41 S 49 S 57 S 65 S 73 
P 1 P 5 S 2 S 10 S 18 S 26 S 34 S 42 S 50 S 58 S 66 S 74 
P 2 N 1 S 3 S 11 S 19 S 27 S 35 S 43 S 51 S 59 S 67 S 75 
P 2 N 1 S 4 S 12 S 20 S 28 S 36 S 44 S 52 S 60 S 68 S 76 
P 3 N 2 S 5 S 13 S 21 S 29 S 37 S 45 S 53 S 61 S 69 S 77 
P 3 N 2 S 6 S 14 S 22 S 30 S 38 S 46 S 54 S 62 S 70 S 78 
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Chapter 4 - Discussion 
This study developed and validated a fluorescent microsphere immunoassay (FMIA) for 
simultaneous detection of antibody responses to three important swine pathogens: PRRSV, SIV 
and PCV2. This assay is the first immunoassay using antigen PCV2 CP (160-233) to detect 
infected animal.  
 
The FMIA is a promising immunoassay for diagnosis and surveillance. It requires a 
smaller sample volume and less time and money compared with the traditional ELISA 
immunoassay. Moreover, it overcomes the limitation of the requirement for a single analyte per 
turn in ELISA. The performance of our FMIA was better in sensitivity compared to the 
commercial ELISA kit where PRRSV was detected in experimentally infected pigs. 
 
In this study, we applied FMIA for epidemiological surveillance of feral swine 
populations in Hawaii and Texas. The seroprevalence of three economically important swine 
pathogens was evaluated.  The antibodies against PCV2 show highest percentage of prevalence 
among these four pathogens in both Hawaiian and Texas feral swine populations. Hence we 
consider PCV2 as the most prevalent pathogen in feral pigs in Hawaii and Texas, and this 
pathogen poses the greatest threat to commercial pigs. SIV seroprevelance increased from 2007 
to 2010 in Hawaii State, suggesting an increasing risk for commercial pigs. Moreover, yearly 
surveillance in Texas State shows an increase in seropositivity to all pathogens, particularly  
PCV2. 
 
After investigation of geographic surveillance, we found antibodies against all three 
viruses were detected on Oahu, whereas, Hawai’i was only seropositive for PCV2. Moreover, 
antibodies to PCV2 indicate Oahu has a higher rate of disease compared with Hawai’i. There is 
also a difference in prevalence among counties in Texas State. Webb County and Aransas 
County possess higher prevalence of PCV2 antibodies (>80%); Calhoun County, Coke County 
and Zapata County show moderate prevalence of PCV2 antibodies (from 37% to 57%);  Leon 
County possesses the lowest prevalence of PCV2 antibodies (26%).   
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The development of FMIA for detection of antibodies to multiple swine pathogens in 
serum samples offers an important alternative for swine disease surveillance in commercial and 
feral herds. Thus FMIA has the potential for detection of broad range of pathogens. Increasing 
the multiplexing capability of FMIA will result in a high-throughput and sensitive platform 
which could apply to diagnostic, epidemiological, and disease surveillance fields.  
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